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Abstract 
Objective 
Painful knee osteoarthritis (KOA) has been associated with joint inflammation. There is 
however little literature correlating signs of localised inflammation with Contrast-enhanced (CE) 
Magnetic resonance imaging (MRI) of synovium. This study examined the relationship between 
clinical and functional markers of localised knee inflammation and CE MRI based synovial 
scores. 
Methods 
Patients with symptomatic KOA were enrolled into the randomised, double-blind, Vitamin D 
Evaluation in Osteoarthritis (VIDEO) trial. In this cross-sectional substudy, associations between 
validated MRI based semi-quantitative synovial scores of the knee and the following markers of 
inflammation were investigated; self-reported pain and stiffness, effusion, warmth, joint line 
tenderness, erythrocyte sedimentation rate, radiographic severity and functional ability tests.  
Results 
107 patients satisfied the inclusion criteria of complete data and were included in the analysis. 
Significant associations were found between the number of regions affected by synovitis and 
WOMAC pain, effusion and joint line tenderness. Each additional region affected by synovitis 
was associated with an increase in WOMAC pain (1.82; 95% CI 0.05-3.58; p=0.04) and the 
association with extent of medial synovitis was particularly strong (3.21; 95% CI 0.43-5.99; 
p=0.02). Extent of synovitis was positively associated with effusion (OR=1.69; 95% CI 1.37-2.08, 
p<0.01), and negatively associated with joint line tenderness (RR= 0.87; 95% CI 0.84-0.90; 
p<0.01). 
Conclusion 
There is a strong positive association between synovitis, and self-reported patient pain and 
clinically detectable effusion. Non-operative treatments directed at management of 
inflammation and future trials targeting the synovial tissue for treating KOA should consider 
these two factors as potential inclusion criteria. 
 
Keywords: Synovitis, Knee Osteoarthritis, Inflammation. 
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Significance & Innovation 
• Knee synovitis is associated with clinically detectable effusion and knee pain. 
• Joint line tenderness is negatively associated with synovial inflammation. 
• We found no correlation between warmth or stiffness and the extent of synovitis. 
• These findings suggest that treatments targeting synovitis might be most effective in 
individuals with knee osteoarthritis associated with clinically detectable effusion. 
1. Introduction 
Osteoarthritis (OA) is the most prevalent form of arthritis and a major cause of morbidity 
worldwide. Synovitis, inflammation of the synovial lining, may be present from the onset of OA, 
tends to increase with radiographic severity and may contribute to the worsening of chondral 
lesions (1). Synovial samples in OA are histologically similar to those of rheumatoid arthritis 
(RA), but are characterized by a trend toward lower cell density (2-4).   
The majority of people with knee pain will have no radiographic changes associated with knee 
osteoarthritis (KOA) and less than 50% of individuals with radiographic KOA will report knee 
pain(5). Microscopic synovitis scores are however greater in individuals with symptomatic 
chondral changes  compared with asymptomatic individuals (6). Knee pain with or without 
radiological evidence of osteoarthritis is associated with significantly increased risk of early 
cardiovascular mortality in middle-age women (7).  Even after adjusting for baseline cartilage 
damage and meniscal tears and extrusions, high levels of synovitis are independently 
associated with new incident of radiographic  KOA(8). 
Contrast-enhanced (CE) Magnetic Resonance Imaging (MRI) permits differentiation of inflamed 
and non-inflammed synovium and is a valuable tool in evaluating synovitis in OA (2, 9-13). Only 
Gd-DTPA–enhanced T1-weighted sequences have the documented ability to enable accurate 
quantification of inflamed synovium (location-specific synovial thickening, volume and rate of 
synovial enhancement on dynamic sequences) resulting in a good association with macroscopic 
and microscopic scores in OA, RA and in spondylarthropathy (9, 14-20). Synovial thickening has 
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been demonstrated on T2-weighted MRI sequences in 73% of joints with early OA  (21) and the 
strong association of knee synovitis with radiographic OA severity and cartlige damage has 
been reported (22).  
Inflammation is classically associated with the five clinical signs: tumor(swelling), dolor(pain),  
rubor(redness), calor (heat), and functio laesa(disturbance of function). A cohort study of OA 
subjects demonstrated that moderate and large effusions with capsular distension and synovial 
thickening were significantly more common among those with knee pain, however, no 
functional evaluation was made [19]. In KOA pain is strongly associated with synovitis, this 
association is stronger than with other intra-articular lesions.(23)  
The aim of this study was to investigate whether self-reported knee pain and other clinical,  
biochemical and physical  markers of localised inflammation correlate well with the extent of 
active synovitis (measured by contrast enhanced MRI). 
 
2. Methods 
2.1 Participants 
 
474 Participants aged 50-79 years with symptomatic, radiographic KOA, and pain in the knee 
for most days in the last month were enrolled in the Vitamin D Evaluation in Osteoarthritis 
(VIDEO ISRCTN94818153) trial; a double-blind, 1:1 randomized placebo controlled trial 
investigating the impact of vitamin D supplementation on the progression of KOA. Daily 
supplementation with 800 IU cholecalciferol did not slow the rate of radiological progression or 
lead to symptoms reduction (24).  For those participants with bilateral radiographic KOA the 
participant was asked which knee was most symptomatic and this was used in analysis. For this 
substudy participants at one of the five VIDEO recruiting centres (Southampton, N=152) were 
included. 
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 2.2 MRI Acquisition 
MRI of the index knee was performed on a single occasion in each participant on a 1.5T Signa 
MRI system (GE Healthcare, Milwaukee, USA) utilising a dedicated phased array knee coil. The 
following pulse sequence protocols were used for the present study:the axial and sagittal T1-w 
fs CE  (TR 620 ms, TE 15.8 ms, slice thickness/slice gap 4.0 mm/0.2 mm, echo train length 2, 
field of view 16.0 x 16.0 cm, matrix size 256 x 160, number of signal averages 2) sequences. The 
contrast-enhanced scans were acquired beginning 3 minutes after intra-venous injection of 0.2 
ml (0.1mmol)/kg body weight Gadodiamide (Omniscan
TM
, GE Healthcare, Little Chalfont, UK). 
As both CE sequences required around 4 min scan time, image acquisition of the CE sequences 
was performed between 3 and 11 minutes after i.v. contrast injection. Image assessment of 
enhancement was performed weeks to months after the images were acquired.  
 
2.3 MRI Interpretation 
Synovitis was scored semi-quantitatively (graded 0 to 3), using a validated scoring system(25), 
at 11 anatomical sites (see supplementary file Table S4). The reading was performed by one 
musculoskeletal radiologist with 8 years’ experience in standardised semi-quantitative 
assessment of knee OA (FWR). The reported intra-reader reliability originally performed on 50 
knees by the same expert reader used in the present study and a second expert 
musculoskeletal radiologist who is a co-author (AG) ranges from 0.67 to 1.00 for the 11 sites. 
  
2.4 Outcomes 
 
Patient self-reported pain was assessed using the WOMAC pain subscale (range 0 to 100, 0 = no 
pain, 100 = extreme pain). Clinical outcomes included effusion (graded 0 to 3), warmth of the 
knee (any or none) and joint line tenderness (JLT) assessed by a trained clinical research nurse 
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(any or none; total, medial and lateral). Erythrocyte sedimentation rate (ESR) was used as a 
biochemical measure of inflammation, whilst Kellgren and Lawrence (KL) grade was used as a 
radiographic measure of structural osteoarthritis severity. Functional outcomes were time 
taken to walk 10 metres and peak supine quadriceps force (SQF) and patient self-reported 
WOMAC stiffness score (range 0 to 100, 0 = no disability, 100 = extreme disability). Where 
possible, outcomes were obtained on the day of the MRI. When outcome data were not 
available for this date, measures from the VIDEO trial visit closest to the MRI were used.   
2.5 Statistical Analysis 
An overall synovitis score was calculated for each participant as the cumulative number of 
regions with a synovitis grade ≥1. A binary synovitis indicator variable, equal to 1 if the sum of 
the 11 regional scores was greater than the median overall synovitis score (patient in the top 
50%) was also generated. Secondary scores included only regions affected in (i) the medial area 
(peripatellar medial and perimeniscal medial) or (ii) the lateral area (peripatellar lateral and 
perimeniscal lateral). The synovitis grades for each of the two regions within each area were 
summed to create medial and lateral scores ranging from 0 to 6 and increase power to detect 
differences between these two regions. 
Multiple linear regression models were used to assess the associations between synovitis and 
the numerical outcomes of interest (WOMAC scores, 10m walk time, peak SQF and ESR). Log-
binomial regression models were used to assess the associations between synovitis and the 
binary outcome variables of interest (Warmth and JLT) and ordinal logistic regression models 
were used when the outcome was ordinal (Effusion and KL grade). All regression models were 
adjusted for the same set of potential confounders: age, gender, body mass index (BMI), the 
presence of Heberden’s nodes and whether the patient had been randomised to receive 
vitamin D supplementation in the VIDEO trial.  
 
To assess whether the association of synovitis with WOMAC pain was independent of KL grade, 
further adjustment for KL grade was made within the analysis model. Where the effect size for 
synovitis remained substantially unchanged or statistically significant, synovitis was assumed to 
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have an association with the outcome at least partially independent of KL grade. The Bayesian 
Information Criteria (BIC) was used to compare models investigating whether synovitis or KL 
grade was most strongly associated with pain. The best model has the minimum value of BIC. A 
reduction in BIC of 2-6 indicates positive evidence for the simpler model, 6-10 indicates strong 
evidence and reductions >10 provide very strong evidence for the simpler model(26). 
 
Southampton VIDEO participants with a complete set of synovitis scores (for all 11 anatomical 
sites) were included in the analysis. Selection bias was investigated by comparing the baseline 
clinical characteristics of those included and excluded from the analysis due to incomplete data. 
For normally distributed continuous data, the two-tailed unpaired t-test was used for 
comparisons. For non-normal continuous data the Mann-Whitney U test was used. All statistical 
analysis was performed using Stata/IC version 11.2, (StataCorp, College Station, TX, USA). 
3. Results 
3.1 Outcome Data  
107 patients satisfied the inclusion criteria of complete MRI and clinical data. There were no 
substantial or significant differences in baseline characteristics between those individuals 
included in the study and those excluded due to incomplete synovitis data (data not shown). 
MRI examination was performed at the baseline VIDEO visit for 43 (40%) patients; at the 12 
month visit for 35 (33%) patients; at the 24 month visit for 27 (25%) patients and at the 36 
month visit for 2 (2%) of the included patients.	WOMAC pain scores were obtained on the date 
of MRI for all patients except one, whose score was obtained at the subsequent VIDEO trial visit 
(6 months post MRI). Table 1 summarises the time between MRI acquisition and outcome 
assessments. 
3.2 Patient Characteristics 
Of those subjects included, 64% were female, with an average age of 65 years and average BMI 
of 29kg/m
2
. 53% were allocated to receive vitamin D supplementation. The median number of 
regions with evidence of synovitis was 9 (range 2 to 11).  Demographic, clinical and 
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inflammatory patient characteristics are compared between those with <9 and ≥9 regions with 
evidence of synovitis in Table 2. Patients with a greater number of regions affected by synovitis 
had higher WOMAC pain scores, were more likely to have Heberden’s nodes, older, with higher 
ESR and higher KL grades. In contrast, JLT was more common amongst those subjects with 
fewer regions affected by synovitis (58% versus 37%). Joint effusion was more common in 
subjects with a greater extent of synovitis.  
 
3.3 Total Synovitis 
 
The association between the total number of regions affected by synovitis and each of the 
outcome measures is summarised in Table 3. A significant association was observed between 
extent of synovitis and the WOMAC pain score. For each additional region affected with 
synovitis there was a 1.82 average increase in WOMAC pain score (95% CI 0.05 to 3.58; p=0.04). 
There was no statistically significant evidence for an association between synovitis and the 
WOMAC stiffness score. 
Synovitis was significantly negatively associated with JLT with a relative risk (RR) of 0.87 (95% CI 
0.84 to 0.90; p<0.01) for each additional region affected by synovitis. Conversely synovitis was 
positively associated with effusion. For each additional region affected by synovitis the odds 
that a patient has a higher effusion grade increases 1.69 times (95% CI 1.37 to 2.08, p<0.01). 
There was no evidence of a significant relationship between warmth and the extent of 
synovitis, however there was limited power to detect differences due to the low number of 
patients presenting with warmth (n=3).  
A significant association was observed between evidence of synovitis and radiographic severity 
as measured using the KL grading system (p<0.01) (Table 3). For each additional region affected 
by synovitis, the odds that a patient has a higher KL grade increases 1.50 times (OR = 1.50; 95% 
CI 1.23 to 1.76; p<0.01). 
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Adjustment of the WOMAC pain model for KL grade indicates that the association observed 
between WOMAC pain and synovitis may not be independent of KL grade (Table 4). The effect 
size attributable to an additional synovitis region after adjustment for KL grade is an increase of 
1.32 in WOMAC Pain score, and no longer statistically significant (p=0.18). The strong 
correlation between KL grade and synovitis led to issues of collinearity. Using Bayesian 
information criterion (BIC) as a model selection criteria there is strong evidence the synovitis 
score is better at predicting WOMAC pain than KL grade (BIC=965.50 versus BIC= 971.58). The 
inclusion of both variables did not improve the fit of the model (BIC=974.24).  There was no 
evidence of an interaction between KL grade and synovitis (p=0.62). 
There was no evidence of any association between the extent of synovitis and ESR, walk time or 
quadriceps strength (Table 3).  
 
3.4 Binary Synovitis Indicator 
A significant relationship between synovitis considered as a binary variable (number of regions 
with synovitis <9 or ≥9) and pain, as measured by the WOMAC pain score was observed. A 
significant association was also found between synovitis (<9 or ≥9) and the KL grade (results not 
shown). 
Synovitis (<9 or ≥9) remained a significant predictor (p=0.02) after adjustment for KL grade 
(Table 5). There was no longer a significant relationship between KL grade and pain, when 
synovitis (<9 or ≥9) was included in the model.  
A comparison of results in Table 5 with adjustment for KL grade to those in Table 4, indicates 
that the model with synovitis as a binary predictor (BIC = 970.60) provides a better fit for pain 
than synovitis treated as a numerical variable (BIC = 974.24). The number of regions with 
synovitis <9 or ≥9, without adjustment for KL grade, is the best predictor of WOMAC pain, 
BIC=961.03. 
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3.5 Medial and Lateral Synovitis 
The median sum of the synovitis grades from the two medial regions (peripatellar medial and 
perimeniscal medial) was 3, range 0 to 5. The extent of lateral synovitis (peripatellar lateral, 
perimeniscal lateral) was slightly lower with a median score of 2, range 0 to 6.  
The relationship between extent of medial synovitis and WOMAC pain score was strongly 
positive with an average 3.21 (95% CI 0.43 to 5.99; p=0.02) point increase in pain score for an 
increase in synovitis grade in a single medial region. This effect size is substantially larger than 
that observed between the total number of regions with synovitis and WOMAC pain (Table 3). 
There was no significant relationship between the extent of lateral synovitis and the WOMAC 
pain score (1.87; 95% CI -0.72 to 4.46; p=0.16) (Table 6).  
 
3.6 Sensitivity Analyses 
 
Only 9 patients with KL Grade 4 were included in analysis, of which only 2 had <9 regions with 
synovitis (Table 2). Sensitivity analysis excluding these 9 patients showed a strong positive 
association between WOMAC pain and synovitis. All other results similarly remained consistent 
in sensitivity analysis (see supplementary file Table S1 to S3).   
ESR fluctuates over time and 55 (51%) participants had ESR tested on the date of MRI.  
Sensitivity analysis was performed in this group and confirmed no evidence of  association 
between ESR and synovitis (0.96, 95% CI 0.85 to 1.07, p=0.512). 
4. Discussion 
 
The findings of this study suggest that there is a strong association between the number of 
regions affected by synovitis and WOMAC pain. Regression models predicting pain from both 
extent of synovitis and KL grade indicated that the best model only included whether or not 
there was synovitis in ≥9 regions. There is also evidence that medial synovitis is more strongly 
associated with pain than lateral synovitis. 
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 Other significant associations found were a positive relationship between effusion and 
synovitis, and a negative association between the extent of synovitis and JLT. The strong 
positive relationship between synovitis and effusion has previously been observed (27) and is 
not unexpected since inflammation of the synovial membrane is frequently accompanied by 
effusion into the synovial sac. The effusion measure may therefore simply be measuring one 
component of the synovitis itself. Further it has been noted that effusion measured from PD FS 
MRI may be measuring both joint effusion and synovial thickening and thus effusion may be 
overestimated (27, 28) which may contribute to the strong associations observed between 
these two measures. 
 
 
The strong positive association identified between the number of regions affected by synovitis 
and KL grade is consistent with previous studies (29). However, in recent years there has been a 
growing acceptance that KL grade does not correlate well with patient experience of pain. 
Some researchers report a threshold effect whereby a small radiographic change is associated 
with substantially increased pain, however further damage does not always appear associated 
with reports of increased pain (30). Previous study of participants with no radiographic 
osteoarthritis found no association between experience of pain, aching or stiffness in the 
previous month and the presence of synovitis(31). However a systematic review of studies of 
osteoarthritis patients did find evidence of a positive association between pain and synovitis 
(32), and this was further supported by the findings of a general population study of middle-
aged women (33). The contrast in these findings is particularly interesting in the context of the 
current study where, whilst both synovitis and KL grade are strong predictors of WOMAC pain 
scores, they are not independent predictors, with the extent of synovitis explaining little 
additional variability in pain compared to KL grade alone. The association between synovitis and 
WOMAC pain in this study does therefore appear to be at least partially mediated by KL grade. 
The high correlation between KL grade and synovitis has been noted previously (33, 34). When 
using BIC as a model selection criteria, synovitis provides a better model for WOMAC pain 
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scores than does KL grade, suggesting that synovitis might more reliably identify patients with 
more painful symptoms. The greater granularity with which synovitis was measured (on a scale 
of 0 to 11) compared to KL scale (on a scale of 0 to 4) needs to be considered and is a possible 
explanation for this finding. That said, in the context of the existing literature these findings do 
support the need for further research into understanding possible interactions between KL 
grade and synovitis in the context of knee pain.  Such a study should ideally consider 
participants with KL grades ranging from 0 to 4. 
This study also investigated whether medial or lateral synovitis was more strongly associated 
with knee pain. The association between the extent of medial synovitis and WOMAC pain score 
was strong and suggests that inflammation of the synovial membrane in medial regions may be 
a mediator of pain in osteoarthritis. In contrast the association between synovitis in the lateral 
region and WOMAC pain was not statistically significant. However the odds ratio of 1.87 does 
suggest that lateral synovitis may still be an important factor in explaining pain in osteoarthritis. 
The possibility that medial synovitis may have a greater role in explaining knee pain than lateral 
synovitis has been suggested previously [26]. Research indicates that knee osteoarthritis is 
more commonly a disease of the medial compartment [27]. The high correlations between KL 
grade and synovitis [24] would therefore lead to an expectation that higher levels of medial 
synovitis would be observed in this (at least equivocal) knee osteoarthritis cohort. In the 
current study the median number of medial regions affected is 3 compared to a median of 2 
lateral regions. However the numbers of participants with any medial or any lateral synovitis 
are very similar (93% versus 91%). Higher prevalence of medial synovitis therefore appears to 
be an unlikely explanation for the finding. It is widely believed that patients with medial knee 
osteoarthritis are more likely to experience painful symptoms. Whilst we are not aware of any 
published study confirming this anecdotal opinion, the current study supports the idea that the 
medial compartment may be more important in determining pain. Further research is required 
to establish whether medial synovitis is influencing any association between medial disease and 
pain.  
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The negative association of synovitis with JLT warrants more consideration. The consistency of 
the associations between any, medial or lateral synovitis with any, medial or lateral JLT provides 
further confirmation of the observed association. However, it is acknowledged that this finding 
contrasts with previous literature which suggests that JLT may be one of the symptoms 
indicative of synovitis. This might indicate that synovitis ascertained through MRI is a distinct 
phenomenon from that measured by traditional methods. Nevertheless, a recent study found a 
strong positive association between MRI measured medial synovitis and medial JLT and no 
association between lateral symptoms in the knees of patients with OA (35). The association 
between JLT and synovitis in patients with painful OA is an area for further investigation. 
The use of gadolinium enhanced MRI to accurately assess synovitis and the detailed nature of 
the clinical assessments provide this study with substantial strengths. However, there are 
several limitations of this study. Aside from the widely accepted limitations of using data from 
trials in terms of generalisability, the sample size is low. There was a high level of exclusion, 
since almost one third of Southampton VIDEO patients did not have complete synovitis data. 
However many of the participants were excluded due to having no contrast enhanced MRI 
sequences or having partial sequences and therefore can be considered to be missing 
completely at random. Statistical analysis found no significant differences in the baseline 
characteristics of those included and excluded from the analysis. A further limitation is the 
discord between the date of MRI assessment of synovitis and effusion, and the date of 
assessment of other clinical and functional outcomes in some patients. However this affected 
only 20% of outcome measures, and only 1 single measure of WOMAC pain and stiffness was 
from a different visit date (within 6 months). Finally, with only limited adjustment for potential 
confounding there is the possibility of residual confounding, particularly in the association 
between synovitis and pain which is known to be confounded by multiple factors. Adjustment 
for further factors such as psychological measures of depression may be warranted in future 
studies.   
5 Conclusion 
The current study indicates that there is a strong positive association between medial 
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compartment synovitis and pain as measured by the WOMAC questionnaire. Clinically 
detectable effusion is also positively associated with synovitis. Non-operative treatments 
directed at management of inflammation and future trials targeting the synovial tissue for 
treating KOA should consider these two factors.  
 
Author Contributions 
All authors were involved in drafting the article or revising it critically for important intellectual 
content, and all authors approved the final version. Prof. Arden had full access to all of the data 
in the study and takes responsibility for the integrity of the data and the accuracy of the data 
analysis. 
 
Authorship Criteria: 
 
1. Gemma Wallace 1c,2,3 
2. Suzie Cro 1c,2,3 
3. Caroline Doré 1a,1c,2,3 
4. Leonard King 1a,1b,2,3 
5. Stefan Kluzek 1c,2,3 
6. Andrew Price 1c,2,3 
7. Frank Roemer 1b,1c,2,3 
8. Ali Guermazi  1b,1c,2, 3 
9. Richard Keen 1a,1b,2,3 
10. Nigel Arden 1a,1b,1c,2,3 
 
  
Page 16 of 25
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
 References 
 
1. Loeuille D, Chary-Valckenaere I, Champigneulle J, Rat AC, Toussaint F, Pinzano-Watrin A, 
et al. Macroscopic and microscopic features of synovial membrane inflammation in the 
osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. 
Arthritis Rheum. 2005;52(11):3492-501. 
2. Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P, Volck B, Jensen CH, Lorenzen I. 
Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in 
rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic 
appearance of the synovium. Arthritis Rheum. 1997;40(10):1856-67. 
3. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J. Synovial membrane 
histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of 
antirheumatic drugs. Arthritis Rheum. 1991;34(2):153-63. 
4. Baeten D. Comparative study of the synovial histology in rheumatoid arthritis, 
spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Annals of 
the Rheumatic Diseases. 2000;59(12):945-53. 
5. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic 
changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27(6):1513-7. 
6. Stoppiello LA, Mapp PI, Wilson D, Hill R, Scammell BE, Walsh DA. Structural associations 
of symptomatic knee osteoarthritis. Arthritis Rheumatol. 2014. 
7. Kluzek S, Sanchez-Santos MT, Leyland KM, Judge A, Spector TD, Hart D, et al. Painful 
knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-
up of a population-based cohort of middle-aged women. Ann Rheum Dis. 2015. 
8. Felson DT, Niu J, Neogi T, Goggins J, Nevitt MC, Roemer F, et al. Synovitis and the risk of 
knee osteoarthritis: the most study. Osteoarthritis Cartilage. 2015. 
9. Gaffney K, Cookson J, Blake D, Coumbe A, Blades S. Quantification of rheumatoid 
synovitis by magnetic resonance imaging. Arthritis & Rheumatism. 1995;38(11):1610-7. 
10. Ahlström H, Feltelius N, Nyman R, Hällgren R. Magnetic resonance imaging of sacroiliac 
joint inflammation. Arthritis & Rheumatism. 1990;33(12):1763-9. 
11. Guermazi A, Roemer FW, Hayashi D, Crema MD, Niu J, Zhang Y, et al. Assessment of 
synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in 
people with, or at high risk of, knee osteoarthritis: the MOST study. Ann Rheum Dis. 
2011;70(5):805-11. 
12. Hayashi D, Roemer FW, Katur A, Felson DT, Yang S-O, Alomran F, et al. Imaging of 
Synovitis in Osteoarthritis: Current Status and Outlook. Seminars in Arthritis and Rheumatism. 
2011;41(2):116-30. 
13. Fotinos-Hoyer AK, Guermazi A, Jara H, Eckstein F, Ozonoff A, Khard H, et al. Assessment 
of synovitis in the osteoarthritic knee: Comparison between manual segmentation, 
semiautomated segmentation, and semiquantitative assessment using contrast-enhanced fat-
suppressed T1-weighted MRI. Magnetic Resonance in Medicine. 2010:n/a-n/a. 
Page 17 of 25
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
14. Drapé JL, Thelen P, Gay-Depassier P, Silbermann O, Benacerraf R. Intraarticular diffusion 
of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation. Radiology. 
1993;188(1):227-34. 
15. Winalski CS, Aliabadi P, Wright RJ, Shortkroff S, Sledge CB, Weissman BN. Enhancement 
of joint fluid with intravenously administered gadopentetate dimeglumine: technique, 
rationale, and implications. Radiology. 1993;187(1):179-85. 
16. Kursunoglu-Brahme S, Riccio T, Weisman MH, Resnick D, Zvaifler N, Sanders ME, et al. 
Rheumatoid knee: role of gadopentetate-enhanced MR imaging. Radiology. 1990;176(3):831-5. 
17. Beltran J, Caudill JL, Herman LA, Kantor SM, Hudson PN, Noto AM, et al. Rheumatoid 
arthritis: MR imaging manifestations. Radiology. 1987;165(1):153-7. 
18. Tamai K, Yamato M, Yamaguchi T, Ohno W. Dynamic magnetic resonance imaging for 
the evaluation of synovitis in patients with rheumatoid arthritis. Arthritis & Rheumatism. 
1994;37(8):1151-7. 
19. König H, Sieper J, Wolf KJ. Rheumatoid arthritis: evaluation of hypervascular and fibrous 
pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology. 1990;176(2):473-7. 
20. Loeuille D, Sauliere N, Champigneulle J, Rat AC, Blum A, Chary-Valckenaere I. Comparing 
non-enhanced and enhanced sequences in the assessment of effusion and synovitis in knee OA: 
associations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage. 
2011;19(12):1433-9. 
21. Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, An T, Negendank WG. Synovial 
thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as 
synovitis. Magnetic Resonance Imaging. 1995;13(2):177-83. 
22. Guermazi A, Hayashi D, Roemer FW, Zhu Y, Niu J, Crema MD, et al. Synovitis in knee 
osteoarthritis assessed by contrast-enhanced magnetic resonance imaging (MRI) is associated 
with radiographic tibiofemoral osteoarthritis and MRI-detected widespread cartilage damage: 
the MOST study. J Rheumatol. 2014;41(3):501-8. 
23. Sofat N, Ejindu V, Kiely P. What makes osteoarthritis painful? The evidence for local and 
central pain processing. Rheumatology. 2011;50(12):2157-65. 
24. Arden NK, Cro S, Sheard S, Dore CJ, Bara A, Tebbs SA, et al. The effect of vitamin D 
supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. 
Osteoarthritis Cartilage. 2016. 
25. Guermazi A, Roemer FW, Hayashi D, Crema MD, Niu J, Zhang Y, et al. Assessment of 
synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in 
people with, or at high risk of, knee osteoarthritis: the MOST study. Annals of the Rheumatic 
Diseases. 2010;70(5):805-11. 
26. Kass RE, Raftery AE. Bayes Factors. Journal of the American Statistical Association. 
1995;90(430):773-95. 
27. Roemer FW, Kassim Javaid M, Guermazi A, Thomas M, Kiran A, Keen R, et al. Anatomical 
distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on 
non-enhanced and contrast-enhanced MRI. Osteoarthritis Cartilage. 2010;18(10):1269-74. 
28. Habib S, Guermazi A, Ozonoff A, Hayashi D, Crema MD, Roemer FW. MRI-based 
volumetric assessment of joint effusion in knee osteoarthritis using proton density-weighted 
fat-suppressed and T1-weighted contrast-enhanced fat-suppressed sequences. Skeletal Radiol. 
2011;40(12):1581-5. 
Page 18 of 25
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
29. Hayes CW, Jamadar DA, Welch GW, Jannausch ML, Lachance LL, Capul DC, et al. 
Osteoarthritis of the Knee: Comparison of MR Imaging Findings with Radiographic Severity 
Measurements and Pain in Middle-aged Women 1. Radiology. 2005;237(3):998-1007. 
30. Creamer P, Lethbridge-Cejku M, Hochberg MC. Determinants of pain severity in knee 
osteoarthritis: effect of demographic and psychosocial variables using 3 pain measures. J 
Rheumatol. 1999;26(8):1785-92. 
31. Guermazi a, Niu J, Hayashi D, Roemer FW, Englund M, Neogi T, et al. Prevalence of 
abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based 
observational study (Framingham Osteoarthritis Study). Bmj. 2012;345:e5339-e. 
32. Yusuf E, Kortekaas MC, Watt I, Huizinga TWJ, Kloppenburg M. Do knee abnormalities 
visualised on MRI explain knee pain in knee osteoarthritis? A systematic review. Annals of the 
Rheumatic Diseases. 2010;70(1):60-7. 
33. Sowers M, Karvonen-Gutierrez CA, Jacobson JA, Jiang Y, Yosef M. Associations of 
anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, 
and physical functioning. J Bone Joint Surg Am. 2011;93(3):241-51. 
34. Krasnokutsky S, Belitskaya-Lévy I, Bencardino J, Samuels J, Attur M, Regatte R, et al. 
Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with 
radiographic severity of knee osteoarthritis. Arthritis & Rheumatism. 2011;63(10):2983-91. 
35. Wenham C.Y. GA, Hensor E.M, Maciewicz R.A., Waterton J.C., Conaghan P. Clinical 
examination findings of the painful OA knee and correlation with MRI abnormalities. Arthritis 
Rheum. 2009;60(Suppl 10):208. 
 
 
Page 19 of 25
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Table 1 – Time (in months) Between MRI and Outcome Assessments 
Outcome 
Recorded on 
date of MRI 
N (%) 
Time between MRI and 
outcome assessment 
Median (Range) 
KL grade 107 (100%) 0 
JLT 107 (100%) 0 
Effusion 107 (100%) 0 
WOMAC (Pain, Stiffness) 106 (99%) 0 (0 to 6) 
Warmth 101 (94%) 0 (0 to 24) 
10m Walk Time 80 (75%) 0 (0 to 12) 
Peak SQF 79 (74%) 0 (0 to 12) 
ESR 55 (51%) 0 (0 to 24) 
 
 
Table 2 –Demographic and Clinical Characteristics of Study Participants 
Baseline  
<9 regions 
with evidence 
of synovitis 
N=48 
≥9 regions 
with evidence 
of synovitis 
N=59 p-value 
Age1 (years) 62 (8) 67(8) 0.01 
Gender2 (male) 21 (44%) 18 (31%) 0.16 
 (female) 27 (56%) 41 (69%)  
BMI1 (kg/m2) 28 (4) 29 (5) 0.43 
Heberden’s Nodes2 (present) 34 (71%) 49 (83%) 0.13 
Vitamin D (VIDEO 
intervention)  
(allocated) 28 (58%) 29 (49%) 0.34 
Vitamin D3 (µg/L) 20.6 (9.9) 22.8 (8.5) 0.21 
Analgesics (taking) 21 (44%) 26 (44%) 0.97 
ESR3 (mm/hr) 2 (0 to 4) 3 (0 to 9) 0.04 
Warmth2 (present) 1 (2%) 2 (3%) 0.68 
JLT2 (present) 28 (58%) 22 (37%) 0.11 
WOMAC Stiffness1,4 (score) 39 (24) 48 (26) 0.09 
WOMAC Pain1,4 (score) 27 (19) 37 (21) 0.01 
Effusion2 0 22 (46%) 7 (12%) <0.01 
 1 17 (35%) 19 (32%)  
 2 8 (17%) 26 (44%)  
 3 1 (2%) 7 (12%)  
10m Walk Time3 (seconds) 8 (7 to 10) 8 (7 to 10) 0.46 
Peak SQF3 (kg) 12 (8 to 16) 10 (5 to 14) 0.08 
KL Grade2 1 15 (31%) 2 (3%) <0.01 
 2 20 (42%) 21 (36%)  
 3 11 (23%) 29 (49%)  
 4 2 (4%) 7 (12%)  
Data is presented as 1mean (standard deviation) for normally distributed variables, 2N 
(%) for categorical variables and 3median (interquartile range) for non-normally 
distributed variables. 4 WOMAC scores range 0 to 100;0 = no pain/disability, 100 = 
extreme pain/disability. 
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Table 3 –Association Between Total Number of Regions with Synovitis and Each 
Outcome Measure (N=107)  
Outcome  Absolute Effect1,2 95% CI p-value 
WOMAC Pain 1.82 0.05 to 3.58 0.04 
WOMAC Stiffness 1.57 -0.66 to 3.81 0.17 
    
 Relative Effect1,3 95% CI p-value 
10m Walk Time (seconds) 0.99 0.97 to 1.02 0.73 
Peak SQF (kg) 0.99 0.95 to 1.04 0.72 
ESR (mm/hr) 0.99 0.92 to 1.06 0.67 
    
 Relative Risk1,4 95% CI p-value 
Warmth 1.49 0.69 to 3.24 0.31 
JLT 0.87 0.84 to 0.90 <0.01 
    
 Odds Ratio1,5 95% CI p-value 
Effusion 1.69 1.37 to 2.08 <0.01 
KL Grade 1.50 1.23 to 1.76 <0.01 
1All regression models are adjusted for age, gender, BMI, presence of Heberden’s nodes and VIDEO trial arm. 
2Absolute effects from linear regression models refer to the increase in the associated outcome variable for one 
further region having evidence of synovitis 
3Relative effects from linear regression models where natural log transformation of the outcome was required 
refer to the relative change in the original untransformed outcome variable for one further region having 
evidence of synovitis. Due to the non-linearity in the relationship between synovitis and ESR, time taken to 
walk 10 metres and peak supine quadriceps force (SQF), the dependent variables were natural log 
transformed. 
4Relative Risks from log binomial regression models refer to the proportional risk of the associated outcome for 
one further region having evidence of synovitis 
5Ordinal regression odds ratios refer to the odds of a higher associated outcome category for one further region 
having evidence of synovitis 
 
 
Table 4 – Association Between Total Number of Regions with Synovitis and 
WOMAC Pain Score After Adjusting for KL grade (N=107) 
WOMAC Pain  
Absolute 
Effect1,2 95% CI p-value 
Test for 
trend 
Synovitis  1.32 -0.61 to 3.25 0.18  
KL Grade 1 Baseline    
 2 6.23 -5.58 to 18.03 0.30 0.12 
 3 4.93 -7.51 to 17.38 0.43  
 4 18.31 1.27 to 35.35 0.04  
1Absolute effect sizes are adjusted for age, gender, BMI presence of Heberden’s nodes and VIDEO trial arm. 
2Absolute effects sizes from the linear regression model refer to the increase in WOMAC pain score for one 
further region having evidence of synovitis 
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Table 5 – Association Between Total Number of Regions with Synovitis 
Categorised into a Binary Score (<9, ≥9 regions) and WOMAC Pain Score 
(N=107) 
WOMAC Pain  
Absolute 
Effect1,2 95% CI p-value 
Test for 
trend 
Model without KL 
Grade: 
     
Synovitis ≥9 regions 11.69 3.79 to 19.58 <0.01  
Model with KL 
Grade: 
     
Synovitis ≥9 regions 9.96 1.34 to 18.58 0.02  
KL Grade 1 Baseline    
 2 4.16 -7.66 to 15.98 0.49 0.21 
 3 2.54 -9.81 to 14.90 0.68  
 4 15.72 -1.07 to 32.51 0.07  
1Absolute effect sizes are adjusted for age, gender, BMI presence of Heberden’s nodes and VIDEO trial arm. 
2Absolute effects sizes from the linear regression model refer to the increase in WOMAC pain score when ≥9 
regions have evidence of synovitis 
  
Page 22 of 25
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
 Table 6 –Association Between Sum of Synovitis Grades Across the Medial and 
Lateral Regions and Outcome Measures (N=107 except JLT lateral where 
N=106) 
 Medial Lateral 
Outcome Absolute 
Effect
1,2 
95% CI p-value Absolute 
Effect
1,2
 
95% CI p-value 
WOMAC Pain 3.21 0.43 to 5.99 0.02 1.87 -0.72 to 4.46 0.16 
WOMAC Stiffness 3.02 -0.50 to 6.55 0.09 2.77 -0.46 to 6.01 0.09 
       
 Relative 
Effect
1,3
 
95% CI p-value Relative 
Effect
1,3
 
95% CI p-value 
10m Walk Time 
(seconds) 
0.90 0.94 to 1.03 0.53 0.97 0.93 to 1.01 0.15 
Peak SQF (kg) 0.96 0.89 to 1.03 0.23 0.97 0.91 to 1.04 0.45 
ESR (mm/hr) 0.95 0.85 to 1.06 0.40 1.01 0.91 to 1.10 0.91 
       
 Relative 
Risk
1,4
 
95% CI p-value Relative  
Risk
1,4
 
95% CI p-value 
Warmth 2.05 0.69 to 6.05 0.19 1.97 0.80 to 4.87 0.14 
JLT Any 0.82 0.71 to 0.95 0.01 0.83 0.72 to 0.96 0.61 
      Medial 0.82 0.69 to 0.98 0.03 0.80 0.67 to 0.95 0.01 
      Lateral 0.81 0.65 to 1.01 0.06 0.82 0.67 to 0.99 0.04 
       
 Odds 
Ratio
1,5
 
95% CI p-value Odds Ratio
1,5
 95% CI p-value 
Effusion 1.87 1.41 to 2.48 <0.01 2.14 1.62 to 2.83 <0.01 
KL Grade 1.77 1.33 to 2.35 <0.01 1.83 1.40 to 2.40 <0.01 
1All regression models are adjusted for age, gender, BMI, presence of Heberden’s nodes and VIDEO trial arm. 
2Absolute effects from linear regression models refer to the increase in the associated outcome variable for a 
one point increase in synovitis grading 
3Relative effects from linear regression models where natural log transformation of the outcome was required 
refer to the relative change in the original untransformed outcome variable for a one point increase in synovitis 
grading 
4Relative Risks from log binomial regression models refer to the proportional risk of the associated outcome for 
a one point increase in synovitis grading 
5Ordinal regression Odds Ratios refer to the odds of a higher associated outcome category for a one point 
increase in synovitis grading 
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